{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:50:51Z","timestamp":1792673451892,"version":"4.5.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Patients who were infected by the <jats:italic>Human Immunodeficiency Virus (<\/jats:italic>HIV) could have weakened immunity that is complicated by opportunistic infections, especially for <jats:italic>Mycobacterium tuberculosis<\/jats:italic> (MTB). Notably, the HIV-MTB co-infection will accelerate the course of disease progress and greatly increase the mortality of patients. Since the traditional diagnostic methods are time-consuming and have low sensitivity, we aim to investigate the performance of mNGS (metagenomic Next-Generation Sequencing) and mNPS (metagenomic NanoPore Sequencing) for the rapid diagnosis of tuberculosis in HIV-infected patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The 122 HIV-infected patients were enrolled for the retrospective analysis. All of the patients underwent traditional microbiological tests, mNGS, and (or) mNPS tests. The clinical comprehensive diagnosis was used as the reference standard to compare the diagnostic performance of culture, mNGS, and mNPS on tuberculosis. We also investigate the diagnostic value of mNGS and mNPS on mixed-infection. Furthermore, the treatment adjustment directed by mNGS and mNPS was analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared with the composite reference standard, the culture showed 42.6% clinical sensitivity and 100% specificity, and the OMT(other microbiological testing) had 38.9% sensitivity and 100% specificity. The mNGS had 58.6% clinical sensitivity and 96.8% specificity, and the mNPS had 68.0% clinical sensitivity and 100% specificity. The proportion of mixed-infection cases (88.9%) in the TB group was higher than those in the non-TB group (54.8%) and the mNGS and mNPS are more competitive on mixed-infection diagnosis compared with the traditional methods. Furthermore, there are 63 patients (69.2%) and 36 patients (63.2%) achieved effective treatment after receiving the detection of mNPS and mNGS, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study indicated that mNPS and mNGS have high sensitivity and specificity for TB diagnosis compared with the traditional methods, and mNPS seems to have better diagnostic performance than mNGS. Moreover, mNGS and mNPS showed apparent advantages in detecting mixed infection. The mNPS and mNGS-directed medication adjustment have effective treatment outcomes for HIV-infected patients who have lower immunity.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2024.1423541","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T11:15:20Z","timestamp":1724325320000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Performance of metagenomic Next-Generation Sequencing and metagenomic Nanopore Sequencing for the diagnosis of tuberculosis in HIV-positive patients"],"prefix":"10.3389","volume":"14","author":[{"given":"Jing","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changgang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qisui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaokai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"key":"B1","first-page":"1106","article-title":"Chinese guidelines for diagnosis and treatment of HIV\/AIDS (2021 edition)","volume":"60","year":"2021","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1128\/JCM.00659-11","article-title":"Isolation of Mycobcic- terium tuberculosis strains with a silent mutation in rpoB leading to potential misassignment of resistance category","volume":"49","author":"Alonso","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"B3","volume-title":"Global tuberculosis report 2019","year":"2019"},{"key":"B4","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41564-019-0626-z","article-title":"pretermmicrobiota and antimicrobial-resistant pathogens","volume":"5","author":"Leggett","year":"2020","journal-title":"Nat. Micro"},{"key":"B5","volume-title":"WHO consolidated guidelines on tuberculosis: Module 3: Diagnosis \u2013 Rapid diagnostics for tuberculosis detection","year":"2024"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/S2666-5247(22)00359-7","article-title":"WHO\u2019s global tuberculosis report 2022","volume":"4","author":"Bagcchi","year":"2023","journal-title":"Lancet Microbe"},{"key":"B7","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/S1473-3099(15)70058-7","article-title":"Burden of tuberculosis at post mortem in inpatients at a tertiary referral centre in sub-Saharan Africa: a prospective descriptive autopsy study","volume":"15","author":"Bates","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41564-018-0349-6","article-title":"Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease","volume":"4","author":"Blauwkamp","year":"2019","journal-title":"Nat. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"S416","DOI":"10.1093\/cid\/ciaa1516","article-title":"Clinical utility of in-house metagenomic next-generation sequencing for the diagnosis of lower respiratory tract infections and analysis of the host immune response","volume":"71","author":"Chen","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41576-019-0113-7","article-title":"Clinical metagenomics","volume":"20","author":"Chiu","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/23744235.2016.1216655","article-title":"Clinical presentation, causes and outcome of febrile episodes in a prospective cohort of HIV-infected patients","volume":"49","author":"De Munter","year":"2017","journal-title":"Infect. Dis. (Lond)."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/cid\/ciy723","article-title":"Prevalence and etiology of community-acquired pneumonia in immunocompromised patients","volume":"68","author":"Di Pasquale","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1183\/09031936.02.01942001","article-title":"Factors associated with unknown aetiology in patients with community-acquired pneumonia","volume":"20","author":"Ewig","year":"2002","journal-title":"Eur. Respir. J."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00526-22","article-title":"Evaluation of metagenomic and targeted next-generation sequencing workflows for detection of respiratory pathogens from bronchoalveolar lavage fluid specimens","volume":"60","author":"Gaston","year":"2022","journal-title":"J. Clin. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41591-020-1105-z","article-title":"Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids","volume":"27","author":"Gu","year":"2021","journal-title":"Nat. Med."},{"key":"B16","first-page":"339","article-title":"Heteroresistance in mycobacterium tuberculosis","volume":"5","author":"Kinder","year":"2001","journal-title":"Int. J. Tuberc Lung Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41564-019-0626-z","article-title":"Rapid MinION profiling of preterm microbiota and antimicrobial-resistant pathogens","volume":"5","author":"Leggett","year":"2020","journal-title":"Nat. Microbiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1080\/23744235.2023.2276785","article-title":"The application of nanopore targeted sequencing for pathogen diagnosis in bronchoalveolar lavage fluid of patients with pneumonia: a prospective multicenter study","volume":"56","author":"Lin","year":"2024","journal-title":"Infect. Dis. (Lond)."},{"key":"B20","doi-asserted-by":"publisher","first-page":"332","DOI":"10.24976\/Discov.Med.202335176.34","article-title":"Comparison of thirdgeneration sequencing technology and traditional microbiological detection in pathogen diagnosis of lower respiratory tract infection","volume":"35","author":"Luo","year":"2023","journal-title":"Discovery Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1101\/gr.238170.118","article-title":"Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid","volume":"29","author":"Miller","year":"2019","journal-title":"Genome Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"776","DOI":"10.5858\/arpa.2016-0539-RA","article-title":"Validation of metagenomic next-generation sequencing tests for universal pathogen detection","volume":"141","author":"Schlaberg","year":"2017","journal-title":"Arch. Pathol. Lab. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12890-019-1022-4","article-title":"Metagenomic next-generation sequencing for mixed pulmonary infection diagnosis","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Pulm Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1056\/NEJMoa1803396","article-title":"Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis","volume":"380","author":"Wilson","year":"2019","journal-title":"N Engl. J. Med."},{"key":"B25","volume-title":"Molecular line probe assays for rapid screening of patients at risk of multi-drug resistant tuberculosis: policy statement","year":"2008"},{"key":"B26","volume-title":"The use of loop-mediated isothermal amplification (TB-LAMP) for the diagnosis of pulmonary tuberculosis: policy guidance","year":"2016"},{"key":"B27","volume-title":"Next-generation Xpert MTB\/RIF Ultra assay recommended by WHO","year":"2017"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.653294","article-title":"Case report: next-generation sequencing in diagnosis of pneumonia due to pneumocystis jirovecii and cytomegalovirus in a patient with HIV infection","volume":"8","author":"Xie","year":"2021","journal-title":"Front. Med. (Lausanne)."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1210857","article-title":"Clinical performance of metagenomic next-generation sequencing for diagnosis of invasive fungal disease after hematopoietic cell transplant","volume":"14","author":"Zhang","year":"2024","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1330788","article-title":"Nanopore sequencing of infectious fluid is a promising supplement for gold-standard culture in real-world clinical scenario","volume":"14","author":"Zhao","year":"2024","journal-title":"Front. Cell Infect. Microbiol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1423541\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T19:31:54Z","timestamp":1724355114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1423541\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":30,"alternative-id":["10.3389\/fcimb.2024.1423541"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2024.1423541","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,21]]},"article-number":"1423541"}}